Allogene Therapeutics, Inc. (NASDAQ:ALLO) Q3 2020 Earnings Conference Call November 4, 2020 8:30 AM ET
Company Participants
Christine Cassiano – Chief Communications Officer
David Chang – President and Chief Executive Officer
Rafael Amado – Executive Vice President-Research and Development and Chief Medical Officer
Eric Schmidt – Chief Financial Officer
Conference Call Participants
Marc Frahm – Cowen
Salveen Richter – Goldman Sachs
Brian Ayman – Jefferies
Tyler Van Buren – Piper Sandler
John Newman – Canaccord
Cory Kasimov – JPMorgan
Michael Schmidt – Guggenheim
Mark Breidenbach – Oppenheimer
Dane Leone – Raymond James
Reni Benjamin – JMP Securities
Raju Prasad – William Blair
Asthika Goonewardene – Truist Securities
Luca Issi – RBC Capital
Ben Burnett – Stifel
Operator
Good morning, ladies and gentlemen. Thank you for standing by, and welcome to Allogene Therapeutics Third Quarter 2020 Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. Please be aware that today's conference call is being recorded.
I would now like to turn the call over to Christine Cassiano, Chief Communications Officer. Ms. Cassiano, please go ahead.
Christine Cassiano
Thank you, operator, and good morning. Before market opened today, Allogene issued a press release that provides a corporate update and financial results for the third quarter ended September 30, 2020. This press release is available on our website at www.allogene.com.
Today's call is being webcast on our website and will be available for replay. Joining me on the call today are Dr. David Chang, President and Chief Executive Officer; Dr. Rafael Amado, Executive Vice President of Research and Development and Chief Medical Officer; and Dr. Eric Schmidt, Chief Financial Officer.
During today's call, we will be making certain forward-looking statements. These may include statements regarding the success and timing of our ongoing
- Read more current ALLO analysis and news
- View all earnings call transcripts